My PCR
Create Account
Logo PCR

22 May 2025

Pharmacotherapy coronary interventions: new insights

Anchorperson: D. Capodanno
Discussants: H. Krumholz, M. Valgimigli, F. Weidinger
SHOW MORE

Summary

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI patients, and long-term outcomes comparing different durations of dual antiplatelet therapy with contemporary stents.

Presentations available when logged in:

  • Ticagrelor monotherapy in chronic coronary syndrome patients post percutaneous coronary intervention
  • Multiple events after PCI in patients at high bleeding risk: a MASTER DAPT trial sub-analysis
  • Effect of BB interruption on blood pressure in MI patients: secondary results of the ABYSS trial
  • Long-term outcomes of 3-to 6-month versus 12-month DAPT after PCI with contemporary stents